Skip to content
Screener

AdaptHealth AHCO Q2 2025 earnings

Reported August 5, 2025 · Before market open

Revenue$800.4MBeat by $1.2M
EPS$0.01Miss by $0.14
Revenue estimate$799.2M
EPS estimate$0.15

Next report

Nov 3, 2026 (in 2 months)
Revenue estimate$725.9M
EPS estimate-$0.05

Financials

Q2 2025

Income statement

See full
Revenue$800.4M-0.7%
Gross profit$154.7M-8.7%
Operating income$79.3M+52.3%
Net income$14.7M-24.5%
EPS (diluted)$0.10-23.1%

Balance sheet

See full
Cash & equivalents$68.6M-1.7%
Total debt$2.0B-12.5%
Total equity$1.6B+6.8%
Total assets$4.4B-3.5%

Cash flow

See full
Operating cash flow$162.0M-18.2%
CapEx$88.7M+9.1%
Free cash flow$73.3M-37.2%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$1.18B-11.1%
Enterprise value$3.06B-12.2%
P/E14.7×—
P/S0.4×0.0×

Profitability

See full
Gross margin19.4%-3.3pp
Operating margin8.1%+4.8pp
Net margin2.5%+1.3pp
FCF margin7.1%+2.0pp

Returns & leverage

See full
Return on equity5.2%+2.8pp
Debt / equity1.2×-0.3×
Current ratio1.1×-0.1×

Segments

By segment

See full
Sleep Health$334.7M+0.9%
Respiratory Health$170.5M+5.6%
Wellness at Home$150.3M-7.2%
Diabetes Health$145.0M-4.1%

FAQ

When did AdaptHealth report Q2 2025 earnings?
AdaptHealth (AHCO) reported Q2 2025 earnings on August 5, 2025 before market open.
What were AdaptHealth's Q2 2025 revenue and EPS?
AdaptHealth reported revenue of $800.4M and eps of $0.01 for Q2 2025.
Did AdaptHealth beat estimates in Q2 2025?
Revenue beat the consensus estimate of $799.2M by $1.2M. EPS missed the consensus estimate of $0.15 by $0.14.
How did AdaptHealth's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 0.7% from $806.0M a year earlier and eps declined 95.2% from $0.21.
Where can I find AdaptHealth's Q2 2025 SEC filings?
You can read the 8-K earnings release (0001628280-25-037598) and the 10-Q periodic report (0001628280-25-037931) directly on SEC EDGAR. The filing index links above go to sec.gov.